Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group.

Journal Information

Full Title: Crit Rev Oncol Hematol

Abbreviation: Crit Rev Oncol Hematol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest Dr. Christian Caglevic: Honoraria: Andes Biotechnologies. Speaker: MSD, BMS, Lilly. Principal Investigator: MSD, GSK, Bayer, Boehringer Ingelheim, Astellas, Roche, Astra Zeneca, BMS, Novartis. Advisory and Consulting: MSD, BMS, Roche, Boehringer Ingelheim. Sponsored Educational Program (including travel, accommodations and expenses): BMS, MSD, Roche. Dr. Suraj Samtani: Speaker: MSD. Advisory and Consulting: MSD, Roche. Sponsored Educational Program (including travel, accommodations and expenses) MSD, Roche, AstraZeneca Mauricio Burotto: Speaker: MSD, Roche, Astra Zeneca, BMS, Novartis. Advisory and Consulting: MSD, BMS, Roche Dr. Santiago Viteri: Dr. Viteri reports personal fees and non-financial support from Roche, personal fees from BMS, non-financial support from OSEPharma, personal fees from MSD, non-financial support from Merck Serono outside the submitted work. Dr. Marisol Arroyo-Hernández: Reports personal fees from AstraZeneca. Dr. Ludwing Bacon: Speaker: AstraZeneca/ Boehringer Ingelheim/ Roche/ Asopharma / Advisor Board: Astra Zeneca / Bayer / Novartis/ Dr. Vladmir Cordeiro de Lima, MD, PhD: Speaker: MSD, BMS, Boehringer-Ingelheim, Roche, Astra-Zeneca. Principal Investigator: BMS, Astra-Zeneca, Janssen, Roche, Millennium, Celgene, MSD. Advisory and Consulting: MSD, BMS, Roche, Boehringer Ingelheim, Astra-Zeneca. Sponsored Educational Program (including travel, accommodations and expenses): BMS, MSD, Astra-Zeneca. Dr. Lucia Viola: Consulting or Advisory Role, Company: AstraZeneca; Travel, Accommodations, Expenses Company: Mundipharma, Boehringer Ingelheim, Astra Zeneca Dr. Luis Mas: speaker Roche, MSD, BMS. Jordi Remon: Advisory/speaker for Boehringer Ingelheim; travel support from Roche, Astra Zeneca, OSE Immunotherapeutics, all outside the submitted work. Dr. Andrés F. Cardona: reports grants from Merck Sharp & Dohme, Boehringer Ingelheim, Roche, Bristol-Myers Squibb and The Foundation for Clinical and Applied Cancer Research – FICMAC., other from Pfizer, Boehringer Ingelheim, Astra Zeneca, MSD, BMS, Celldex, Roche, personal fees from Merck Sharp & Dohme, Boehringer Ingelheim, Roche, Bristol-Myers Squibb, Pfizer, Novartis, Celldex Therapeutics, Foundation Medicine, Eli Lilly and Foundation for Clinical and Applied Cancer Research – FICMAC, outside the submitted work. Dr. Oscar Arrieta reports personal fees from Pfizer, grants and personal fees from Astra zeneca, grants and personal fees from Boehringer Ingelheim, personal fees from Lilly, personal fees from Merck, personal fees from Bristol Myers Squibb, grants and personal fees from Roche, outside the submitted work. All the remaining authors declare no conflict of interest."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025